Identification of Autoantibodies against TRPM1 in Patients with Paraneoplastic Retinopathy Associated with ON Bipolar Cell Dysfunction-Reference-Cited by-同舟云学术

Identification of Autoantibodies against TRPM1 in Patients with Paraneoplastic Retinopathy Associated with ON Bipolar Cell Dysfunction

Published:2011-05-17 Issue:5 Volume:6 Page:e19911
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kondo Mineo,Sanuki Rikako,Ueno Shinji,Nishizawa Yuji,Hashimoto Naozumi,Ohguro Hiroshi,Yamamoto Shuichi,Machida Shigeki,Terasaki Hiroko,Adamus Grazyna,Furukawa Takahisa

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells.;CE Thirkill;N Engl J Med,1989

2. Paraneoplastic retinopathies and optic neuropathies.;JW Chan;Surv Ophthalmol,2003

3. Autoimmune retinopathy: A review and summary.;JR Heckenlively;Semin Immunopathol,2008

4. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy.;G Adamus;Autoimmun Rev,2009

5. Cancer-associated retinopathy.;CE Thirkill;Arch Ophthalmol,1987

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-TRPM1 autoantibody-positive unilateral melanoma associated retinopathy (MAR) triggered by immunotherapy recapitulates functional and structural details of TRPM1-associated congenital stationary night blindness;American Journal of Ophthalmology Case Reports;2024-12

2. Paraneoplastic retinopathies: an update on pathogenesis, diagnosis and management;Annals of Eye Science;2024-03

3. Retinal Dysfunction Caused by Autoimmune Mechanisms;Medical and Surgical Retina - Recent Innovation, New Perspective, and Applications;2023-08-30

4. SpikeSEE: An energy-efficient dynamic scenes processing framework for retinal prostheses;Neural Networks;2023-07

5. B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma;Nature Communications;2023-06-08